These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


196 related items for PubMed ID: 11825742

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
    Watanabe M, Hasegawa N, Ishizaka A, Asakura K, Izumi Y, Eguchi K, Kawamura M, Horinouchi H, Kobayashi K.
    Ann Thorac Surg; 2006 Jun; 81(6):2026-30. PubMed ID: 16731124
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Outcomes and risk factors after adjuvant surgical treatments for Mycobacterium avium complex lung disease.
    Yamada K, Seki Y, Nakagawa T, Hayashi Y, Yagi M, Ogawa K.
    Gen Thorac Cardiovasc Surg; 2019 Apr; 67(4):363-369. PubMed ID: 30390231
    [Abstract] [Full Text] [Related]

  • 6. Surgical management of Mycobacterium avium complex disease.
    Ono N, Satoh K, Yokomise H, Tamura K, Horikawa S, Suzuki Y, Nishiyama H, Maekawa N.
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):311-3. PubMed ID: 9477466
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pneumonectomy for nontuberculous mycobacterial infections.
    Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N.
    Ann Thorac Surg; 2004 Aug; 78(2):399-403. PubMed ID: 15276484
    [Abstract] [Full Text] [Related]

  • 9. The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment.
    van Ingen J, Egelund EF, Levin A, Totten SE, Boeree MJ, Mouton JW, Aarnoutse RE, Heifets LB, Peloquin CA, Daley CL.
    Am J Respir Crit Care Med; 2012 Sep 15; 186(6):559-65. PubMed ID: 22744719
    [Abstract] [Full Text] [Related]

  • 10. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
    Adachi Y, Tsuyuguchi K, Kobayashi T, Kurahara Y, Yoshida S, Kagawa T, Hayashi S, Suzuki K.
    J Infect Chemother; 2020 Jul 15; 26(7):676-680. PubMed ID: 32171660
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease.
    Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ.
    Am J Respir Crit Care Med; 2006 Oct 15; 174(8):928-34. PubMed ID: 16858014
    [Abstract] [Full Text] [Related]

  • 13. [Results of surgery in Mycobacterium avium complex pulmonary disease].
    Nakao S, Matsumoto H, Sasaki N, Takahashi M, Sato K, Takeda A, Fujita Y, Yamazaki Y, Tobise K, Nagase A, Tsuji T.
    Nihon Kokyuki Gakkai Zasshi; 2000 Oct 15; 38(10):756-61. PubMed ID: 11186921
    [Abstract] [Full Text] [Related]

  • 14. Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease.
    Kadota T, Matsui H, Hirose T, Suzuki J, Saito M, Akaba T, Kobayashi K, Akashi S, Kawashima M, Tamura A, Nagai H, Akagawa S, Kobayashi N, Ohta K.
    BMC Infect Dis; 2016 Jan 27; 16():31. PubMed ID: 26818764
    [Abstract] [Full Text] [Related]

  • 15. [Video assisted thoracic surgery for Mycobacterium avium complex pulmonary disease spread over multiple pulmonary lobe within one lung].
    Ueshima Y, Kurioka H, Yamada R, Takumi C, Hiraoka N, Ono S.
    Nihon Kokyuki Gakkai Zasshi; 2005 Oct 27; 43(10):618-21. PubMed ID: 16285596
    [Abstract] [Full Text] [Related]

  • 16. Bronchoscopy as a Useful Examination for Determining Surgical Treatment Indications in Refractory Mycobacterium avium Complex Lung Disease Patients with Bilateral Lesions.
    Tabata E, Sekine A, Hagiwara E, Tajiri M, Ogura T.
    Intern Med; 2019 Apr 01; 58(7):973-978. PubMed ID: 30449787
    [Abstract] [Full Text] [Related]

  • 17. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
    Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ.
    Clin Infect Dis; 2000 Feb 01; 30(2):288-92. PubMed ID: 10671330
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Macrolide resistant Mycobacterium avium complex pulmonary disease following clarithromycin and ethambutol combination therapy.
    Ito Y, Miwa S, Shirai M, Kanai M, Fujita K, Ohba H, Iwaizumi E, Oshima T, Kojima S, Suda T, Hayakawa H.
    Respir Med; 2020 Aug 01; 169():106025. PubMed ID: 32442113
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.